Pulmonx Corporation gains attention as healthcare strength highlights its emphysema-focused Zephyr Valve and Chartis patient ...

A newly approved cholesterol-lowering pill could offer millions of people a more convenient way to dramatically reduce "bad" ...

Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”), a global leader in minimally invasive treatments for lung disease, today announced that it will release financial results for the second quarter of 2026 ...

In 1996, the Cigarette Papers was published, revealing how Kentucky’s Tobacco and Health Research Institute at the University ...

Millions of Americans are breathing unhealthy or even hazardous air as winds push smoke from wildfires raging in Canada ...

The poor air quality Thursday was the equivalent of smoking four to six cigarettes in a day, according to a professor of ...

Rheumatoid arthritis is associated with increased respiratory-related mortality in non-tuberculosis mycobacterial pulmonary ...

Quince Therapeutics, Inc. (Nasdaq: QNCX), a clinical stage biopharmaceutical company focused on the development of novel, disease modifying therapies for serious underserved diseases, today announced ...

As Canada grapples with hundreds of active wildfires, the rest of North America is feeling the impactsstruggles with air quality alerts. In Philadelphia and elsewhere, the air quality score is ...

So far July of 2026 has featured a triple whammy of major health crises: Extreme heat, wildfire smoke tainting the air to ...

Nuvaira, a developer of novel therapeutic strategies to treat obstructive lung diseases has announced the first patient treated in its pivotal randomized trial of dNerva® targeted lung denervation ...